Are you Dr. McCarville?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1020 Vestal Pkwy E
Vestal, NY 13850Phone+1 607-754-5342Fax+1 607-754-5508
Summary
- Dr. Michael McCarville, MD is an internist in Vestal, New York. He is currently licensed to practice medicine in New York. He is affiliated with Our Lady of Lourdes Memorial Hospital, Inc..
Education & Training
United Health Services HospitalsResidency, Internal Medicine, 1986 - 1988
Universidad Autonoma de GuadalajaraClass of 1983
Certifications & Licensure
NY State Medical License Active through 2014
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Publications & Presentations
PubMed
- 5 citationsBenefits and profitability of fluopyram-amended seed treatments for suppressing sudden death syndrome and protecting soybean yield a meta-analysisYuba R. Kandel, Michael T. McCarville, Eric Adee, Jason P. Bond, Martin I. Chilvers
Plant Disease. 2017-11-21 - 15 citationsSoybean Aphid Infestation Induces Changes in Fatty Acid Metabolism in SoybeanCharles Kanobe, Michael T. McCarville, Matthew E. O'Neal, Gregory L. Tylka, Gustavo C. MacIntosh
Plos One. 2015-12-18 - 21 citationsReduced Fitness of Virulent Aphis glycines (Hemiptera: Aphididae) Biotypes May Influence the Longevity of Resistance Genes in Soybean.Adam J. Varenhorst, Michael T. McCarville, Matthew E. O'Neal
Plos One. 2015-09-15
Press Mentions
Benefits and Profitability of Fluopyram-Amended Seed Treatments for Suppressing Sudden Death Syndrome and Protecting Soybean Yield: A Meta-AnalysisNovember 22nd, 2017
